Ropilynz XL 4 mg prolonged-release tablets Egyesült Királyság - angol - myHealthbox

ropilynz xl 4 mg prolonged-release tablets

lupin (europe) limited - ropinirole - prolonged-release tablet - 4mg - dopamine agonists - treatment of parkinson's disease under the following conditions: initial treatment as monotherapy, in order to delay the introduction of levodopa in combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).

Ropilynz XL 8 mg prolonged-release tablets Egyesült Királyság - angol - myHealthbox

ropilynz xl 8 mg prolonged-release tablets

lupin (europe) limited - ropinirole - prolonged-release tablet - 8mg - dopamine agonists - treatment of parkinson's disease under the following conditions: initial treatment as monotherapy, in order to delay the introduction of levodopa in combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).